Psychological complications of patients with Gaucher disease
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
The Minnesota Multiphasic Personality Inventory (MMPI-2) is commonly used in chronic illness and chronic pain populations to assess psychological functioning. We report the results of the first study employing the MMPI-2 to assess psychological aspects of patients with Gaucher disease, type I (GD) is an inborn error of metabolism with unique features as a chronic illness: the disorder often presents with mild symptoms, and is frequently diagnosed in later childhood or adulthood; the treatment is highly efficacious, but, that same treatment is intrusive and expensive and requires that patients restructure their work and personal schedules. In this study, 28 patients with GD completed the MMPI-2 and a background questionnaire. GD patients scored significantly higher than the MMPI-2 normative sample on MMPI-2 scales of Validity (K), Hypochondriasis (Hs), Depression (D), Hysteria (Hy), Psychasthenia (Pt) and Schizophrenia (Sc). Individuals with elevated scores on the Hs, D and Hy scales tend to have somatic concerns and depressed mood. Under stress, they are likely to report physical symptoms. Elevated Pt and Sc scales suggest psychological turmoil and, possibly feelings of isolation. An elevated K scale indicates a tendency for individuals to deny psychopathology. The length of time the patient with GD had been on enzyme replacement therapy was not significantly related to any of the 13 MMPI-2 scales. Cohorts of patients with chronic heart disease (CRHD) and cohorts of patients with chronic pain were utilized as comparative populations in this investigation. The elevated scores of the GD patients on MMPI-2 scales Hs, D and Hy were similar to those of the CRHD population. The chronic pain patients also showed elevations on MMPI-2 scales Hs, D and Hy, which were elevated in the GD patients; the elevations in the chronic pain patients were higher than those shown by the GD patients. We conclude that patients with GD exhibit moderate to severe psychological complications, similar to patients with other long-term chronic illnesses.
- Barton NW, Brady RO, Dambrosia JM, et al (1991) Replacement therapy for inherited enzyme deficiency—macrophage-targeted glucocerebrosidase for Gaucher’s disease. N Engl J Med 324: 1464–1470.
- Beutler E (1991) Gaucher’s disease. N Engl J Med 19: 1354–1360.
- Brady RO, Kanfer JN, Shapiro D (1965) Metabolism of glucocerebrosides. II. Evidence of an enzymatic deficiency in Gaucher’s disease. Biochem Biophys Res Commun 18: 221–225. CrossRef
- Butcher JN, Dahlstrom WG, Graham JR, Tellegen A, Kaemmer B (1989) MMPI-2: Manual for Administration and Scoring. Minneapolis: University of Minnesota Press.
- Charrow J, Esplin JA, Gribble TJ, et al (1998) Gaucher disease: recommendations on diagnosis, evaluation, and monitoring. Arch Intern Med 158: 1754–1760. CrossRef
- Damiano AM, Pastores GM, Ware JE (1998) The health-related quality of life of adults with Gaucher’s disease receiving enzyme replacement therapy: results from a retrospective study. Qual Life Res 7: 373–386. CrossRef
- Devins GM, Binik YM (1996) Facilitating coping with chronic physical illness. In: Zeidner M, Endler NS, eds. Handbook of Coping: Theory, Research, Applications. Oxford: Wiley, 640–696.
- Enns G, Packman W (2002) The adolescent with an inborn error of metabolism: medical issues and transition to adulthood [Review]. Adolesc. Med 13(2): 315–329.
- Esplin JA (1994) Overview: Gaucher disease Gaucher Clin Perspect 2: 3–16.
- Gaucher PCE (1882) De l’epithelioma primitif de la rate, hypertrophie idiopathique de la rate sans leucemie. Doctoral thesis, Paris, France.
- Grabowski GA, Leslie N, Wenstrup R (1998) Enzyme replacement therapy for Gaucher disease: the first 5 years. Blood Rev 12: 115–133. CrossRef
- Graham JR (2000) MMPI-2: Assessing Personality and Psychopathology, 3rd edn. New York: Oxford University Press.
- Greene RL (2000) The MMPI-2: An Interpretive Manual, 2nd edn. Needham Heights: Allyn and Bacon.
- Grewal RP (1993) Psychiatric disorders in patients with Fabry’s disease. Int J Psychiatry Med 23: 307–312.
- Hathaway SR, McKinley JC (1940) A multiphasic personality schedule (Minnesota): I. Construction of the schedule. J Psychol 10: 249–254.
- Hayes, RP, Grinzald KA, Duffey EB, Elsas LJ (1998) The impact of Gaucher disease and its treatment on quality of life. Qual Life Res 7: 521–534. CrossRef
- Kirkcaldy BD, Kobylinska E (1987) Psychological characteristics of breast cancer patients. Psychother Psychosom 48: 32–43.
- Maruta T, Swanson DW, Swenson WM (1976) Low back pain in a psychiatric population. Mayo Clin Proc 51: 57–61.
- Masek BJ, Sims KB, Bove CM, Korson MS, Short P, Norman DK (1999) Quality of life assessment in adults with type 1 Gaucher disease. Qual Life Res 8: 263–268. CrossRef
- Naliboff BD, Cohen MJ, Yellin AN (1982) Does the MMPI differentiate chronic illness from chronic pain? Elsevier Biomedical Press 13: 333–341.
- Varvagoli L, Waisbren SE (1999) Personality profiles of mothers of children with mitochondrial disorders. J Inherit Metab Dis 22: 615–622.
- Zhao H, Grabowski GA (2002) Gaucher disease: perspectives on a prototype lysosomal disease. Cell Mol Life Sci 59: 694–707.
- Psychological complications of patients with Gaucher disease
Journal of Inherited Metabolic Disease
Volume 29, Issue 1 , pp 99-105
- Cover Date
- Print ISSN
- Online ISSN
- Kluwer Academic Publishers
- Additional Links
- Industry Sectors